1-12 of 12
Ruth R. French
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivo

Thomas R. W. Tipton, C. Ian Mockridge, Ruth R. French, Alison L. Tutt, Mark S. Cragg, Stephen A. Beers
Journal: Blood
Blood (2015) 126 (24): 2643–2645.
https://doi.org/10.1182/blood-2015-09-671339
Published: 2015
Includes: Supplemental data
Journal Articles

Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies

Thomas R. W. Tipton, Ali Roghanian, Robert J. Oldham, Matthew J. Carter, Kerry L. Cox, C. Ian Mockridge, Ruth R. French, Lekh N. Dahal, Patrick J. Duriez, Philip G. Hargreaves, Mark S. Cragg, Stephen A. Beers
Journal: Blood
Blood (2015) 125 (12): 1901–1909.
https://doi.org/10.1182/blood-2014-07-588376
Published: 2015
Includes: Supplemental data
Journal Articles

Upregulation of FcγRIIb on monocytes is necessary to promote the superagonist activity of TGN1412

Khiyam Hussain, Chantal E. Hargreaves, Ali Roghanian, Robert J. Oldham, H. T. Claude Chan, C. Ian Mockridge, Ferdousi Chowdhury, Bjorn Frendéus, Kirsty S. Harper, Jonathan C. Strefford, Mark S. Cragg, Martin J. Glennie, Anthony P. Williams, Ruth R. French
Journal: Blood
Blood (2015) 125 (1): 102–110.
https://doi.org/10.1182/blood-2014-08-593061
Published: 2015
Includes: Supplemental data
Journal Articles

Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy

Sean H. Lim, Andrew T. Vaughan, Margaret Ashton-Key, Emily L. Williams, Sandra V. Dixon, H. T. Claude Chan, Stephen A. Beers, Ruth R. French, Kerry L. Cox, Andrew J. Davies, Kathleen N. Potter, C. Ian Mockridge, David G. Oscier, Peter W. M. Johnson, Mark S. Cragg, Martin J. Glennie
Journal: Blood
Blood (2011) 118 (9): 2530–2540.
https://doi.org/10.1182/blood-2011-01-330357
Published: 2011
Includes: Supplemental data
Journal Articles

Non-Cognate Cytotoxic T Cells Can Be Retargeted Against CD20 Positive Tumour Cells Using [Fab' × MHC Class I/Peptide] Conjugates.

Angela D Hamblin, BA, MRCP, Ben CR King, PhD, Ruth R French, PhD, Claude H Chan, PhD, Alison L Tutt, MPhil, Philip M Savage, PhD, FRCP, Peter W Johnson, MD, FRCP, Martin J Glennie, PhD
Journal: Blood
Blood (2010) 116 (21): 2838.
https://doi.org/10.1182/blood.V116.21.2838.2838
Published: 2010
Journal Articles

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

Stephen A. Beers, Ruth R. French, H. T. Claude Chan, Sean H. Lim, Timothy C. Jarrett, Regina Mora Vidal, Sahan S. Wijayaweera, Sandra V. Dixon, Hyungjin Kim, Kerry L. Cox, Jonathan P. Kerr, David A. Johnston, Peter W. M. Johnson, J. Sjef Verbeek, Martin J. Glennie, Mark S. Cragg
Journal: Blood
Blood (2010) 115 (25): 5191–5201.
https://doi.org/10.1182/blood-2010-01-263533
Published: 2010
Includes: Supplemental data
Journal Articles

Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation

Stephen A. Beers, Claude H. T. Chan, Sonya James, Ruth R. French, Kathrine E. Attfield, Claire M. Brennan, Anupama Ahuja, Mark J. Shlomchik, Mark S. Cragg, Martin J. Glennie
Journal: Blood
Blood (2008) 112 (10): 4170–4177.
https://doi.org/10.1182/blood-2008-04-149161
Published: 2008
Includes: Supplemental data
Journal Articles

Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation

Ruth R. French, Vadim Y. Taraban, Graham R. Crowther, Tania F. Rowley, Juliet C. Gray, Peter W. Johnson, Alison L. Tutt, Aymen Al-Shamkhani, Martin J. Glennie
Journal: Blood
Blood (2007) 109 (11): 4810–4815.
https://doi.org/10.1182/blood-2006-11-057216
Published: 2007
Includes: Supplemental data
Journal Articles

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells

Brief Report
Mark S. Cragg, Mike B. Bayne, Alison L. Tutt, Ruth R. French, Stephen Beers, Martin J. Glennie, Timothy M. Illidge
Journal: Blood
Blood (2004) 104 (8): 2540–2542.
https://doi.org/10.1182/blood-2004-05-1733
Published: 2004
Journal Articles

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

Jessica L. Teeling, Ruth R. French, Mark S. Cragg, Jeroen van den Brakel, Marielle Pluyter, Haichun Huang, Claude Chan, Paul W. H. I. Parren, C. Erik Hack, Michael Dechant, Thomas Valerius, Jan G. J. van de Winkel, Martin J. Glennie
Journal: Blood
Blood (2004) 104 (6): 1793–1800.
https://doi.org/10.1182/blood-2004-01-0039
Published: 2004
Journal Articles

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

Mark S. Cragg, Suzanne M. Morgan, H. T. Claude Chan, B. Paul Morgan, A. V. Filatov, Peter W. M. Johnson, Ruth R. French, Martin J. Glennie
Journal: Blood
Blood (2003) 101 (3): 1045–1052.
https://doi.org/10.1182/blood-2002-06-1761
Published: 2003
Journal Articles

The Importance of Antibody-Specificity in Determining Successful Radioimmunotherapy of B-Cell Lymphoma

Timothy M. Illidge, Mark S. Cragg, Harry M. McBride, Ruth R. French, Martin J. Glennie
Journal: Blood
Blood (1999) 94 (1): 233–243.
https://doi.org/10.1182/blood.V94.1.233.413a25_233_243
Published: 1999